|Number of pages||1|
|Publication status||Published - 16 Nov 2006|
|Event||48th Annual Meeting of the American-Society-of-Hematology - Orlando, United States|
Duration: 09 Dec 2006 → 12 Dec 2006
Modifier genetics in zebrafish identify Chk1 and an associated survival pathway as targets for pharmacotherapy of MDS/AML with P53 mutations.
Samuel Sidi, Andreas T. Hagen, Richard Kennedy, Shintaro Imamura, Shuji Kishi, John Kanki, Alan D'Andrea, A. Thomas Look
Research output: Contribution to journal › Meeting abstract › peer-review